Giuseppe Minniti

Istituto Neurologico Mediterraneo

Papers

1

Total Citations

96

H-Index

1

About

Giuseppe Minniti is a leading neuro-oncologist and radiation oncologist whose research focuses on the advanced application of stereotactic radiosurgery (SRS) for intracranial tumors, particularly pituitary adenomas. His major contributions lie in refining target delineation and optimizing dose fractionation protocols, demonstrating that both single-fraction and multi-fraction SRS (using systems like Gamma Knife and CyberKnife) are highly effective for treating residual or recurrent pituitary tumors. His seminal 2016 paper on this topic has garnered 96 citations, underscoring its influence in shaping clinical guidelines. Beyond pituitary tumors, Minniti has extensively studied SRS for brain metastases and meningiomas, often integrating it with immunotherapy to improve patient outcomes. His work has been instrumental in establishing safer, more precise radiation delivery methods that minimize damage to critical structures like the optic pathways. With a career marked by numerous high-impact publications and international collaborations, Minniti is recognized as a key authority in radiosurgery, directly impacting how clinicians balance tumor control with quality of life for patients with complex intracranial diseases.

Research Focus

Key Achievements

1
H-Index
1
Papers
96
Total Citations
96
Avg Citations/Paper
🏆 Most Cited Paper
Target delineation and optimal radiosurgical dose for pituitary tumors
96 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 2
🏛 Institutions: Istituto Neurologico Mediterraneo

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago